Bladder cancer drug adstiladrin studied in everyday practice

NCT ID NCT06026332

Terminated Knowledge-focused Sponsor: Ferring Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 202 bladder cancer patients who were prescribed Adstiladrin (nadofaragene firadenovec) in real-world clinics in the US and Israel. Researchers wanted to see how often the drug led to complete remission and how long that lasted. The study was terminated early, so the full picture may not be available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Adstiladrin (nadofaragene firadenovec)
What this could lead to: If successful, this could show how well Adstiladrin works in everyday medical practice for bladder cancer patients.
What could go wrong: The study was terminated early, so results may be limited. It was also observational, meaning it only watched what happened without strict controls.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Non-Muscle Invasive Bladder Neoplasms urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER

Contacts and locations

Locations

AMP UROLOGY, Syracuse - US Urology Partners

Syracuse, New York, 13210, United States
Arkansas Urology, North Little Rock

Little Rock, Arkansas, 72211, United States
Atlantic Urology Clinics - McLeod Health Blvd

Myrtle Beach, South Carolina, 29579, United States
Banner Health MD Anderson Cancer Center

Gilbert, Arizona, 85234, United States
Central OH Urology Group - US Urology Partners

Gahanna, Ohio, 43230, United States
Emory University

Atlanta, Georgia, 30308, United States
First Urology Research (Jeffersonville)

Jeffersonville, Indiana, 47130, United States
Florida Urology Partners

Riverview, Florida, 33578, United States
Florida Urology Partners

St. Petersburg, Florida, 33701, United States
Florida Urology Partners

Tampa, Florida, 33607, United States
Florida Urology Partners

Tampa, Florida, 33615, United States
Georgia Urology

Atlanta, Georgia, 30328, United States
Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States
Mayo Clinic

Jacksonville, Florida, 32225, United States
Mayo Clinic - Rochester Minnesota

Rochester, Minnesota, 55905, United States
Mayo Clinic Arizona

Phoenix, Arizona, 85054, United States
Minnesota Urology

Woodbury, Minnesota, 55125, United States
Montefiore Medical Center (Bronx2)

The Bronx, New York, 10461, United States
Mount Sinai Medical Center

Miami Beach, Florida, 33140, United States
SUNY Upstate Medical University Syracuse

Syracuse, New York, 13210, United States
The Urology Center, PC

Omaha, Nebraska, 68114, United States
UF Health Surgical Specialists - Gainesville

Gainesville, Florida, 32610, United States
UROLOGY OF INDIANA - GREENWOOD FQ: Urology of Indiana US Uro Partners

Greenwood, Indiana, 46143, United States
USC Norris Comprehensive Cancer Center

Los Angeles, California, 90033, United States
University of Texas Southwestern Medical Center (Dallas)

Dallas, Texas, 75390, United States
University of Utah (Salt Lake City)

Salt Lake City, Utah, 84112, United States
University of Virginia Health System

Charlottesville, Virginia, 22908, United States
Urology Associates P C (Nashville)

Nashville, Tennessee, 37209, United States
Urology Associates of Central California

Fresno, California, 93720, United States
Urology of Virginia (Virginia Beach)

Virginia Beach, Virginia, 23462, United States
Wichita Urology - Wichita Webb

Wichita, Kansas, 67226, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.